Elon Musk loses landmark OpenAI lawsuit while AI advances in healthcare, security, and consumer tech, with major legal and ethical questions reshaping the industry.

Elon Musk lost his lawsuit against OpenAI and Sam Altman, with a nine-member panel taking only two hours to return a verdict in favor of OpenAI, raising major questions about trust and governance in AI development.

NYC Health and Hospitals suffered a significant data breach affecting at least 1.8 million people, with hackers stealing medical data and fingerprints, highlighting cybersecurity vulnerabilities in healthcare AI systems.

Kin Health raised $9 million to develop an AI notetaker for patients, demonstrating growing investment in AI-powered healthcare solutions that could improve clinical documentation and patient care.

Amazon introduced Alexa+ with a new feature capable of generating podcast episodes using AI, expanding the company's audio content capabilities and AI-driven content creation.

Google launched the DeepMind Accelerator program in Asia Pacific and announced free AI literacy training for 6 million K-12 educators, signaling major corporate investment in AI education and environmental sustainability initiatives.

Apple is revamping Siri with auto-deleting chat functionality, addressing privacy concerns as major tech companies compete to build more privacy-conscious AI assistants.

The US government is deploying AI to catch insider trading in prediction markets, marking a significant regulatory use case for machine learning in financial crime detection.

Bug bounty platforms are being bombarded with AI-generated submissions and slop, creating operational challenges as AI-powered content generation undermines quality control in security research programs.

South Korea's LetinAR is developing advanced optics for AI-powered glasses, representing progress in spatial computing and wearable AI hardware that could reshape human-computer interaction.

CAR-T cell therapy, an AI-optimized immunotherapy originally developed for cancer, is showing early promise in managing HIV long-term, demonstrating AI's expanding role in precision medicine and biological research.